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High-throughput sequencing has the power to reveal the nature of adaptive immunity as
represented by the full complexity of T-cell receptor (TCR) and antibody (IG) repertoires,
but is at present severely compromised by the quantitative bias, bottlenecks, and accu-
mulated errors that inevitably occur in the course of library preparation and sequencing.
Here we report an optimized protocol for the unbiased preparation of TCR and IG cDNA
libraries for high-throughput sequencing, starting from thousands or millions of live cells
in an investigated sample. Critical points to control are revealed, along with tips that allow
researchers to minimize quantitative bias, accumulated errors, and cross-sample contam-
ination at each stage, and to enhance the subsequent bioinformatic analysis. The protocol
is simple, reliable, and can be performed in 1–2 days.
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INTRODUCTION
Next generation sequencing (NGS) technologies opened a breath-
taking opportunity to perform deep analysis and comparative
studies of the T-cell receptor (TCR) and antibody (IG) repertoires
of the human donors and model animals, as well as of the vari-
ous sorted, separated, or cultured lymphocyte subsets of interest
(1–13). Still, rational NGS-analysis of such immune repertoires is
critically dependent on the library preparation protocols, starting
from a lymphocytes/PBMC sample and ending with the amplifi-
cation of individual TCR/IG segment encoding molecules on the
solid phase of a sequencing machine. Multiple sampling bottle-
necks, PCR biases, and cross-contamination at different stages lie
in wait to trick a researcher on his way to get the deep, clear, and
congruent data.
While studying autoimmunity and hematopoietic stem cell
transplantation therapy (10, 14–17), we have optimized cDNA-
based protocol that allows unbiased pre-sequencing amplification
of the human and murine,alpha- and beta-TCR,as well as IG heavy
chain gene libraries. The protocol employs a specific oligonu-
cleotide to prime cDNA synthesis, and template switching effect to
form a universal 5′-adapter and to introduce sample barcode at the
very first stage of library preparation. Subsequent two-step PCR
amplification is performed with universal pairs of primers for the
whole library using step-out plus PCR-suppression effect (18) on
the 5′-end and nested PCR (19) on the 3′-end of the library (16).
This approach allows efficient and unbiased amplification
of millions of the TCR/IG mRNA molecules in only 27–30
(21–24 considering dilution factor, see below) PCR cycles, thus
providing sufficient starting material for the deep NGS-analysis of
complex lymphocyte samples. Current protocol is optimal for the
sequencing on Illumina MiSeq/HiSeq platforms and Roche 454
platforms.
Here we report the upgraded and tested protocol in a ready-to-
use format with the technical details required for the method to
be easily and uniformly reproduced in any laboratory.
ADVANTAGES OF cDNA LIBRARIES AND 5′-TEMPLATE
SWITCH
Starting with cDNA synthesis using 5′-template switching (16, 20,
21) has at least two decisive advantages in comparison with the
genomic DNA-based approaches (2, 12).
First, the whole diversity of variable chains (up to approxi-
mately 100 different V gene segment variants1, can be amplified
using just a pair (for TCRs) or a simple multiplex set (for IGs)
of oligonucleotides, specific to the template switch adapter on the
5′-end and to the constant gene segments on the 3′-end of the
library (Figure 1).
In contrast, the approaches starting with the genomic DNA
require multiplex primer sets to be used both at the 5′ V gene seg-
ments’ end, and at the 3′ introns/J-segments end of the library (2).
Moreover, a subsequent nested PCR amplification, which requires
1http://www.imgt.org/
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FIGURE 1 | Flow-chart of the library preparation protocol from
RNA and to NGS-ready PCR product. XXXXX: optional sample
barcodes (see Sample Barcoding in Appendix for details and
Supplementary Material for barcodes). *For TCR alpha/beta profiling
with 100 nt sequencing length, multiplexed J-segment-specific
primers should be used as a reverse primer in the second PCR
amplification step as described in section “Next Generation
Sequencing Options.”
another set of multiplex primers, can be necessary to obtain pure
TCR or IG library from genomic DNA. Multiplexing inevitably
leads to dramatic bias in relative efficiency of amplification of
different variable segments and thus to the loss of quantitative
information, and complete loss of some of the rare clonotypes
(10, 16, 22, 23).
Second, abundant copies of mRNAs encoding TCR or IG chains
comprise an essential portion of the total lymphocyte RNA. This
practically results in an efficient amplification of a deep library
starting from 106 mRNA molecules from a 3µg of total RNA sam-
ple purified from three million PBMC cells (10). cDNA synthesis
reaction can be performed in a volume of 10–15µl in a single PCR
tube (see Protocol), allowing multiple parallel experiments to be
carried out.
In contrast, amplification of the TCR/IG library starting from
15µg of genomic DNA of the same three million PBMC sample
requires PCR to be carried out in larger volumes (since no more
than 0.5µg of genomic DNA can be taken for a 50µl PCR reac-
tion), and still does not provide comparable PCR efficiency, i.e.,
essential portion of the original sample diversity is lost due to the
stochastic character of PCR, inevitably missing rare molecules.
LIMITATIONS OF THE USE OF cDNA LIBRARIES AND
5′-TEMPLATE SWITCH
We have recently demonstrated that cDNA-based template switch-
ing protocol is highly quantitative at the ensemble level – the level
of relative TRBV gene segments’ frequencies (10). Indeed, PCR
bias is minimized and the whole approach is quite quantitative
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in respect of relative abundance of mRNA molecules at start and
sequencing reads at the end of analysis pipeline. However, it should
be noted that individual T-cell or B-cell clones can potentially be
characterized by higher or lower expression levels of TCR or IG
mRNA (24, 25). This limitation should be kept in mind when
using NGS data for the estimation of particular lymphocyte clones’
relative abundance.
It is generally important that the cells being analyzed “feel fine”
and contain a sufficient amount of TCR/IG mRNA. Therefore, it
is preferable to purify total RNA from a freshly isolated cell sample
for the native analysis. For the frozen samples, overnight incuba-
tion of thawed cells in presence of IL2 (Roche, 15 U/ml) leads to
at least twofold increase of TCR genes RNA expression levels (our
unpublished observations).
Differences in the efficiency of reverse transcription and tem-
plate switching may lead to a different number of cDNA molecules
read per T- or B-cell. Therefore, it is important to use the same
reverse transcriptase and 5′-template switch adapter and carry out
all the procedures in identical experimental conditions to obtain
results that can be further accurately compared at the deep level
(e.g., in an analysis of relative diversity of naïve T cells or a PBMC
sample, etc.).
EXPERIMENTAL DESIGN: CELLS, NUMBERS, AND
BOTTLENECKS
The desirable depth of TCR or IG repertoire analysis depends on
the particular experimental questions raised. For example,applica-
tion of the current protocol for the deep analysis of a PBMC sample
containing 106 T cells will provide quantitative data on those TCR
clonotypes that constitute at least 0.01–0.1% of all T cells in a
sample (100–1000 T cells) (10). The majority (>95%) of TCR
clonotypes constituting at least 0.001% (at least 10 T cells) will
be sequenced, while approximately 20–40% of TCR clonotypes
represented by a single T cell in a sample may be lost (estimated
according to our quantitative experiments, depends on the reverse
transcriptase used). Preferably, all the synthesized cDNA should
be used for the first PCR amplification step. Second PCR should
result in sufficient amount of target PCR product in a reasonable
number of amplification cycles (see Protocol). The desirable num-
ber of output CDR3-containing high quality sequencing reads is
at least 2× 106 per sample (see Protocol and Expected Results).
Much smaller bottleneck limits should be quite sufficient for the
majority of the experimental tasks concerning more specific sub-
populations of lymphocytes characterized by lower diversity [such
as sorted antigen-specific T cells (26) or B cells (27)]. For example,
10,000 lymphocytes, 10 ng high quality total RNA, no more than
21 first PCR cycles, no more than 20 s PCR cycles (see Protocol and
Expected Results), and at least 30,000 CDR3-containing sequenc-
ing reads (ideally 100,000 reads to achieve over-sequencing) per
sample may be sufficient to identify most TCR/IG clonotypes in a
low-complexity sample. It is preferable to use reverse transcriptase
with high 5′-template switching efficiency (e.g., SMARTScribe,
Clontech) when small cell samples/RNA amounts are analyzed.
EXPERIMENTAL DESIGN: SAMPLE BARCODES,
MULTIPLEXED SEQUENCING, CROSS-CONTAMINATION
Since as few as 30,000 sequencing reads per sample may be
sufficient for many experimental tasks in immune repertoire’s
profiling, and, for example, paired end 150 bp Illumina MiSeq
run can produce more than five million good quality TCR/IG
CDR3 reads, a researcher may be often interested in sequenc-
ing multiple samples in a single run. At the same time, ligat-
ing Illumina sample barcodes to 10 or more samples is rather
expensive and laborious. Our design suggests that sample bar-
codes can be introduced within the 5′-template switch adapter
during cDNA synthesis and/or second PCR amplification steps
(see Figure 1). Samples with the barcodes inside can be then
combined in equal (or unequal, if it is desirable to get more
reads for some samples) proportions, and Illumina adapters
can be ligated to the resulting pooled PCR library of approxi-
mately 500–600 bp length (see Protocol and Sample Barcoding in
Appendix).
Sample barcodes on both ends of the library allow to eliminate
most cross-contaminations between the samples sequenced in the
same run/lane that may occur during the amplification of the com-
bined sample after adapters’ ligation, and potentially in course of
bridge amplification on the solid phase of the sequencing machine.
To avoid contamination on the earlier stages of pre-sequencing
library preparation, all procedures, including: RNA purification,
cDNA synthesis, first and second PCR preparation – should be
performed in separate clean PCR boxes.
PROTOCOL
PREPARING STARTING MATERIAL – TOTAL RNA
1. Use standard Trizol (Invitrogen) or QIAzol (QIAGEN), or other
analogous protocol for RNA isolation. Alternatively,use RNeasy
kit (QIAGEN), or other column-based RNA isolation method.
Depending on the starting material, consider the following
RNA purification procedures:
A. For small amount of whole blood (less than 100µl) use
1 ml of Trizol or specific RNA isolation kits (for example,
QIAamp RNA Blood Kit, QIAGEN).
B. For large amount of whole blood, preferably perform
preliminary PBMC separation using standard procedures
(Ficoll density gradient separation) and proceed to C.
C. For large amount of white blood cells, use 1 ml of Trizol
(per up to 107 cells). If using column-based RNA isola-
tion method for the large amount of cells, DNase treatment
is necessary (according to a manufacturer protocol) since
large amounts of genomic DNA significantly affect cDNA
synthesis.
D. For small amount of cells (below 100,000 live cells, for
example, sorted or bead-separated T or B cells), preferably
perform isolation of total RNA shortly after cell acquisi-
tion, in order to minimize loss of live cells and mRNA.
When using Trizol protocol, add a co-precipitant (e.g., Pel-
let Paint, Millipore) to the aqueous phase before adding
isopropyl alcohol. It is highly desirable that the precipitant
forms a single well-defined spot. This provides confidence
that some portion of the material will not be washed off by
EtOH. Do not discard EtOH used to wash the sample until
you are convinced that library preparation has been per-
formed successfully, since some portion of RNA can remain
in EtOH.
All the cell/RNA isolation, cDNA synthesis and first PCR prepa-
ration steps should be carried out in a clean DNA/RNAase free
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room or a PCR box with no contact with any TCR-containing
PCR products to prevent contamination. Standard RNA sam-
ples handling precautions should be used (gloves, labcoats,
filtered tips, and certified RNAase free reagents) to avoid RNA
degradation.
Time: 1–2 h.
Pause: RNA can be stored in 70% ethanol at−70°C for at least
a year.
cDNA SYNTHESIS AND TEMPLATE SWITCH
2. Mix the following in a final volume of 4µl in a sterile
thin-walled reaction tube (mix1).
Component Amount, µl Final concentration*
RNA 1–3 Maximum 2µg
cDNA synthesis
primer(s) (20µM)**
0.5–1.5 (0.5 each) 1µM for each primer
mQ 0–2.5
*Final concentration/amount in 10µl after adding mix2 (see Step 5).
**SeeTable 1 for primers used. Simultaneous synthesis of TCR alpha and beta
cDNA is possible (tested for both human and mouse) in case if limited starting
material is available. Simultaneous synthesis of IgA, IgM, and IgG heavy chains
cDNA is also possible (tested for human).
Put no more than 1.5–2µg of total RNA per 10µl of final
reaction volume. For the extra-deep profiling use propor-
tional volume to obtain cDNA from desired amount of
starting RNA.
3. Place the reaction tube(s) into a thermal cycler and incubate
for 4 min at 70°C and then for 2 min at 42°C to anneal synthesis
primer(s).
4. While incubating, mix the following in a separate tube in a final
volume of 6µl (mix2).
Component Amount, µl Final concentration*
First strand buffer (5×, Evrogen or
Clontech)
2 1×
DTT (20µM) 1 2µM
5′-template switch adapter (10µM) 1 1µM
dNTP solution (10 mM each) 1 1 mM each
Mint reverse transcriptase (10×,
Evrogen) or SMARTScribe reverse
transcriptase (10×, Clontech)
1 1×
*Final concentration in 10µl after adding mix 2.
5. Add mix2 to mix1 and mix by pipetting, incubate 40–60 min at
42°C.
Reverse transcriptases are heat sensitive. Allow the mixture to
chill to 42°C after first step denaturation at least for 2 min as
described.
Reverse transcriptases are not equal in their 5′-template
switching activity. We have extensive experience with Mint
and SMARTScribe reverse transcriptases that provide reliable
5′-template switching.
6. (Optional, for Mint Reverse transcriptase only, to enhance tem-
plate switching activity) Add 5µl of IP solution (Evrogen) and
incubate at 42°C for additional 1 h.
7. (Optional, see Unique Molecular Identifiers in Appendix) Add
1µl of Uracyl DNA glycosylase (5 U/µl, New England Biolabs)
and incubate 1 h at 37°C.
Time: 2–3 h.
Pause: although cDNA is generally stable, we prefer not to
store cDNA longer than several hours at +4°C for the deep
profiling experiments. Freezing small amounts of cDNA is
undesirable.
FIRST PCR AMPLIFICATION
8. In a sterile thin-walled tube(s) mix the following in a final
volume of 25µl.
Component Amount, µl Final concentration
First strand cDNA 1
Tersus buffer (10×, Evrogen) 2, 5 1×
dNTP (2.5 mM each) 1, 5 0.15 mM each
Primer smart20 (10µM) 1 0.4µM
Reverse primer(s) (10µM)* 1–3 (1 each) 0.4µM (each)
Tersus polymerase mix (50×,
Evrogen)
0.5 1×
mQ 17.5–15.5
*SeeTable 1 for primers used. Simultaneous amplification ofTCR alpha and beta
cDNA is possible (tested for both human and mouse) in case if limited starting
material is available. Simultaneous amplification of IgA, IgM, and IgG heavy chains
cDNA is also possible (tested for human).
Put no more than 1µl of cDNA from the synthesis reac-
tion per 25µl PCR reaction volume. For the deep profiling,
use proportional number of tubes to amplify all the cDNA
obtained.
Polymerase with high fidelity and processivity should be used
for amplification.
9. Carry out 18 (when starting from large amount of cells) or 21
(when starting from small amount of cells) cycles of ampli-
fication using the following program: 95°C for 20 s, 65°C for
20 s, 72°C for 50 s.
10. Combine all the first step PCR products and purify a portion
using the QIAquick PCR purification Kit (or other column-
based purification system).
Time: 2–3 h.
Pause: purified first PCR product can be stored at −20°C for
a month as a source for the re-amplification of material in the
second PCR.
SECOND PCR AMPLIFICATION
11. Mix the following in a sterile thin-walled tube in a final volume
of 25µl.
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Component Amount, µl Final concentration
Purified first PCR product 1
10× polymerase buffer (e.g., Tersus
buffer, Evrogen)
2.5 1×
dNTP (2.5 mM each) 1.5 0.15 mM each
Primer Step1 (10µM) 1 0.4µM
Reverse primer (10µM)* 1 0.4µM
50× polymerase (e.g., Tersus
polymerase, Evrogen)
0.5 1×
mQ 17.5
*SeeTable 1 for primers used. For primer design options see Sample Barcoding,
Unique Molecular Identifiers, and Introducing Diversity at the Ends of the Library
in Appendix. In case of simultaneous cDNA synthesis and first PCR amplification
of TCR alpha and beta chain libraries, second PCR for TCR alpha and beta chain
libraries preparation should be performed in separate reactions. Use an aliquot of
purified first PCR product to generateTCR beta library (with beta specific primer)
and TCR alpha library (with alpha specific primer).
Polymerase with high fidelity and processivity should be used
for amplification.
12. Carry out amplification using the following program: 95°C
for 20 s, 65°C for 20 s, 72°C for 50 s, 9–12 cycles (up to 18–
20 cycles if starting from minimal amounts of RNA); final
elongation at 72°C for 5 min).
Purify the PCR products using QIAquick PCR purification Kit
(or other column-based purification system) at the same day.
This step is important since it removes the residual enzyme
activities that can damage the obtained PCR library.
Time: 2 h.
Pause: libraries can be stored at −20°C for weeks before
adapter ligation.
MIXING THE BARCODED SAMPLES FOR MULTIPLEX SEQUENCING
In order to combine several PCR libraries with pre-introduced
sample barcodes (see Figure 1 and Sample Barcoding in Appendix
for possible options), perform the following:
13. Determine the concentration of each library using the QuBit
Fluorometer.
14. Combine samples in a sterile microcentrifuge tube propor-
tionally to the desirable amount of sequencing reads per
sample. A total amount of PCR products should be approx-
imately 0.5–1µg (specify the required amount of the PCR
product in a sequencing center).
Alternatively, each sample can be ligated to sequencing adapters
with different sample barcodes separately. Samples are mixed in
desirable proportions before sequencing.
NEXT GENERATION SEQUENCING OPTIONS
Design of the current protocol is optimized for the Illumina paired
end 2× 150 nt (or 2× 300 nt for IGs) sequencing as the most
reliable way to obtain unbiased TCR/IG repertoire. The paired end
sequencing is obligatory when double sample barcodes (see and
Sample Barcoding in Appendix) and/or unique molecular identi-
fiers (see Unique Molecular Identifiers in Appendix) are used. If
no unique molecular identifiers are used, and sample barcoding is
used on the 3′-end of the library only (Figure 1), then single end
sequencing is possible. However, only half of obtained sequencing
reads will contain the CDR3 region.
Protocol also suits well the Roche 454 sequencing technology.
Frequent length-errors in reading homogenous oligonucleotide
stretches on this platform should be kept in mind, and proper
error-correction algorithms utilized (10).
In order to use Illumina paired end 2× 100 nt sequenc-
ing for TCRs, the only required modification is that multi-
plexed J-segment-specific primers should be used instead of the
reverse primer in the second PCR amplification step. This minor
multiplexing within limited number of PCR cycles does not
lead to essential quantitative bias and allows sequence to start
closer to the CDR3 region of interest, as described (10, 16).
For IG’s heavy chain, the universal J-segment-specific primer
(Table 1) is close to CDR3 already and no modifications are
necessary.
Alternative strategy is that sequences for Illumina flow cell and
custom sequencing primers can be introduced in the course of
amplification (not shown on Figure 1). Although potentially ben-
eficial, it requires thorough design in cooperation with sequencing
centers.
This protocol is not adopted for Ion Torrent as these sequenc-
ing machines have limitations in the maximal length of ana-
lyzed sequencing library. Multiplex PCR mix for the V-segment
is required for Ion Torrent library preparation, albeit leads to
significant quantitative bias during amplification (10).
To provide better cluster differentiation, ask sequencing facility
to spike the library with 10–30% of PhiX and/or design primers
as described in Introducing Diversity at the Ends of the Library in
Appendix.
Size selection on agarose gel after ligation of adapters is
strongly recommended since even minor amounts of short non-
specific PCR products can significantly reduce target sequences
output.
SOFTWARE ANALYSIS OF NGS DATA
Output NGS data on TCR/IG profiling contain numerous
errors accumulated during reverse transcription, PCR ampli-
fication, and sequencing. For the latter, higher Phred quality
score only means lower frequency of sequencing errors. Thus,
high sequence quality does not guarantee absence of sequenc-
ing errors. Generally, the more we sequence, the more erro-
neous TCR/IG variants we generate. Without appropriate error-
correction, NGS data can generate artificial TCR/IG diversity
exceeding the native diversity of complex input library up to
several-fold (10).
Several approaches were proposed to correct the PCR and high
quality sequencing errors in TCR datasets, suggesting to filter off
low frequency TCR variants (8), to filter off the low abundance
variants with single mismatch comparing to the major clonotypes
(7), or to correct single mismatch errors in germline segments by
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Table 1 | Oligonucleotides.
Primer Application Sequence*,**
FIRST STRAND cDNA SYNTHESIS
Switch_oligo 5′ adapter: template switch adapter, universal for all libraries AAGCAGTGGTATCAACGCAGAGTAC(XXXXX)TCTT(rG)5
SmartNNN Alternative template switch adapter with unique molecular
identifier (see Unique Molecular Identifiers in Appendix),
universal for all libraries
AAGCAGUGGTAUCAACGCAGAGUNNNNUNNNNUNNNNUCTT(rG)5
AC1R Primer for cDNA synthesis, human TCR alpha mRNA ACACATCAGAATCCTTACTTTG
BC1R Primer for cDNA synthesis, human TCR beta mRNA CAGTATCTGGAGTCATTGA
Mus_alfa_synt1 Primer for cDNA synthesis, mouse TCR alpha mRNA TTTCGGCACATTGATTTG
BC_mus_syn1 Primer for cDNA synthesis, mouse TCR beta mRNA CAATCTCTGCTTTTGATG
HCA-rt Primer for cDNA synthesis, human IgA heavy chain mRNA GTCCGCTTTCGCTCCAGG
HCM-rt Primer for cDNA synthesis, human IgM heavy chain mRNA GATGTCAGAGTTGTTCTTG
HCG-rt Primer for cDNA synthesis, human IgG heavy chain mRNA GTGTTGCTGGGCTTGTG
FIRST PCRAMPLIFICATION
Smart20 Step-out primer 1. Anneals on the switch_oligo, universal for all
libraries
CACTCTATCCGACAAGCAGTGGTATCAACGCAG
AC2R Nested primer 1, human TCR alpha library TACACGGCAGGGTCAGGGT
BC2R Nested primer 1, human TCR beta library TGCTTCTGATGGCTCAAACAC
Mus AV2 rev Nested primer 1, mouse TCR alpha library GGTGCTGTCCTGAGACCGAG
BC4_mus_Rev Nested primer 1, mouse TCR beta library GATGGCTCAAACAAGGAGACC
HCA-n1 Nested primer 1, human IgA heavy chain library GCGATGACCACGTTCCCATCT
HCM-n1 Nested primer 1, human IgM heavy chain library GTGATGGAGTCGGGAAGGAAG
HCG-n1 Nested primer 1, human IgG heavy chain library GAAGTAGTCCTTGACCAGGCA
SECOND PCRAMPLIFICATION
Step_1 Step-out primer 2, from the Smart20, universal for all libraries (N)2–4(XXXXX)CACTCTATCCGACAAGCAGT
Hum bcj Nested primer 2, human TCR beta (N)2–4(XXXXX)ACACSTTKTTCAGGTCCTC
Hum acj Nested primer 2, human TCR alpha (N)2–4(XXXXX)GGGTCAGGGTTCTGGATAT
Mus bcj Nested primer 2, mouse TCR beta (N)2–4(XXXXX)GGAGTCACATTTCTCAGATCCT
Mus acj Nested primer 2, mouse TCR alpha (N)2–4(XXXXX)CAGGTTCTGGGTTCTGGATGT
IGHJ-r1 Nested primer 2, human IG heavy chain (universal for IgA, IgG,
and IgM)
(N)2–4(XXXXX)GAGGAGACGGTGACCRKGGT
*XXXXX: optional sample barcode (see Figure 1, and Sample Barcoding in Appendix for details and Supplementary Material for barcodes). U=dU (deoxyuridine).
**(N)2–4 – optional. Random nucleotides (“N”) are introduced at the 5′ end of final library in order to generate diversity for better cluster identification on Illumina
sequencer (see Introducing Diversity at the Ends of the Library in Appendix for details).
mapping to the major clonotypes (10). Low quality sequences can
be either filtered off (7, 8) or mapped to the high quality ones in
order to rescue quantitative information (10).
There are currently three available software packages for
NGS TCR data analysis: IMGT/HighV-QUEST web service2,
Decombinator (28), and our new software, named MiTCR3 (29).
Note that IMGT/HighV-QUEST is limited to only 50,000–150,000
sequences per batch and thus it is hardly suitable for the analysis
of deep NGS profiling data. MiTCR is the only software package
that considers sequence quality, performs correction of PCR and
sequencing errors, and rescues low quality sequencing data. Two
basic error-correction modes are currently implemented, aiming
either to eliminate maximal number of accumulated errors, or
to preserve maximal original TCR diversity, albeit with less effi-
cient error-correction. Moreover, analysis parameters can be tuned
2http://www.imgt.org/IMGTindex/IMGTHighV-QUEST.html
3http://mitcr.milaboratory.com/
by user in a wide range to obtain optimal result for the particu-
lar experimental task. Output format is a tab-delimited file or a
special *.cls file for the MiTCR-Viewer software (Figure 2).
EXPECTED RESULTS
RNA
The quality and quantity of obtained RNA is critical for the library
generation. Quality of total RNA is evaluated by two visible bands
on electrophoresis (or two highest peaks on Agilent Bioanalyzer)
corresponding to 18S and 28S rRNA. The relative amount of two
bands should be between 1:2 and 1:1. The expected yield is 1–
3µg of total RNA from one million of PBMC when using Trizol
protocol. If starting material is limited (10,000 cells or less) RNA
should be completely used in one cDNA synthesis reaction without
analyzing by electrophoresis.
NUMBER OF PCR CYCLES
In order to preserve natural TCR/IG diversity of the sample it is
important to minimize the number of PCR cycles used for library
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FIGURE 2 | MiTCR-viewer outputs for the analyzedTCR beta dataset. (A)Table with clonotypes. (B) In silico spectratyping.
preparation. In our system, maximal number of PCR cycles should
be 18 for the first and 12 for the second amplification step if
starting from 2µg of total RNA. A well visible band is observed
on electrophoresis after 12 cycles of second PCR amplification
(that is at least 50 ng of PCR product per 25µl reaction). For a
minimum amount of starting material (below 10,000 cells) the
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maximum number of PCR cycles should be 21 for the first and
18–20 for the second amplification step. If the number of cycles
needed to obtain a visible band is higher, this may indicate that low
number of molecules has successfully entered amplification, thus
leading to uncertain detection of CDR3 clonotypes of the input
sample.
SEQUENCING OUTPUT AND ANALYSIS
With the use of the proposed protocol, at least three million of
high quality CDR3-containing sequencing reads from a paired end
MiSeq run and at least 100 million CDR3-containing sequenc-
ing reads from one lane of paired end HiSeq 2,000/2,500 run
are expected. The number of different clonotypes depends on
the nature and amount of starting material. For example, pro-
filing of 5–10 million human PBMC cells using 1/10 of HiSeq
2000 Illumina lane (at least 10 million CDR3-containg reads) can
yield from 0.5 to 2.5 million TCR beta CDR3 clonotypes after
appropriate error-correction.
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APPENDIX
SAMPLE BARCODING
When sequencing multiple samples, it is recommended to intro-
duce sample barcodes during the library preparation process. This
allows to minimize cross-sample contamination and to treat all
samples as the single one when ligating Illumina adapters. It is
possible to introduce sample barcodes on different stages (See
Figure 1). One of the best ways is to use 5′-template switch adapters
with built-in sample barcodes, thus labeling each sample at the
very first library preparation step. Alternatively/additionally, 5′-
end sample barcode can be introduced at the 5′-end of the Step-out
primer 2 (see Table 1). We also recommend introduction of sample
barcodes within the reverse primers used in the second amplifi-
cation step (hum bcj, hum acj, mus bcj, mus acj, or IGHJ-r1, see
Table 1). Using this approach, each sample is barcoded at both
ends of the library. This is crucial when accurate comparison of
two or more samples is required, as we observe different levels of
swapping ends between molecules in course of standard Illumina
library preparation stage and presumably on the solid phase of the
sequencer, during bridge amplification. For your convenience, we
have generated a list of 5-nucleotide sample barcodes, which differ
from each other by at least two nucleotides (see Supplementary
Material), thus minimizing the chance of barcode misinterpre-
tation if the single error occurs during sample preparation or
sequencing.
UNIQUE MOLECULAR IDENTIFIERS
Unique molecular identifiers can be introduced as random
oligonucleotides at the very first amplification (or cDNA synthesis)
step of library preparation (30). Each molecule that successfully
enters amplification becomes labeled by a unique combination
of nucleotides – a molecular identifier. Thus each TCR/IG CDR3
sequence variant in the output NGS dataset is characterized by a
number of distinct molecular identifiers indicating the number of
such cDNA molecules that have entered the PCR amplification.
This approach allows to correct the PCR bias that occurs dur-
ing amplification and to count mRNA/cDNA molecules of each
type directly, which makes the TCR/IG repertoire analysis even
more quantitative. Unique molecular identifiers consisting of 12
random nucleotides (which give approximately 17 million unique
variants) can be introduced within the 5′-template switch adapter
(Table 1, SmartNNN). This template switch adapter also contains
multiple deoxyuridine nucleotides. After cDNA synthesis, Ura-
cyl DNA glycosylase treatment allows to eliminate SmartNNN,
thus preventing possible exchange of unique molecular identifiers
during following PCR amplification (30).
INTRODUCING DIVERSITY AT THE ENDS OF THE LIBRARY
The common problem with sequencing PCR products by Illu-
mina is the presence of the same nucleotides in the beginning of
most sequencing reads. This can lead to a fail of a sequencing
run as Illumina software cannot discriminate adjacent clusters,
which produce identical fluorescent signals during the first sev-
eral sequencing cycles. The common solution used by sequenc-
ing centers is spiking the sequencing library by PhiX library
containing random DNA fragments. However, in this case, the
number of obtained target sequences is decreased by at least
30%. To avoid this problem we introduce two to four random
nucleotides (“N”) to the 5′ end of the primers used in the sec-
ond amplification step (see Table 1). Preferably, the number of
“N” nucleotides flanking the library should be different for the
samples mixed on the same Illumina lane, in order to generate
additional diversity of starting sequencing steps and to avoid iden-
tical nucleotides being present in the same positions, which may
alter Illumina sequencing quality. If one sample is sequenced per
Illumina lane and no sample barcodes are used, it is recommended
to use a mixture of three identical primers, each containing a
different number of “N” nucleotides at the 5′ end – e.g., (N)2
Step1/(N)3 Step 1/(N)4 Step1, the same with the reverse primer
(see Table 1).
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